Amneal Pharmaceuticals, Inc. EPS (Earnings per Share) 2016–2025
Amneal Pharmaceuticals, Inc. reported $0.22 of earnings per share for fiscal 2025. That was 157.9% higher than fiscal 2024. Compared with fiscal 2020, the change was -63.9%.
| Fiscal year | EPS (Earnings per Share) | Change (YoY) |
|---|---|---|
| FY 2025 | $0.22 | +157.9% |
| FY 2024 | $-0.38 | +20.8% |
| FY 2023 | $-0.48 | +44.2% |
| FY 2022 | $-0.86 | -1328.6% |
| FY 2021 | $0.07 | -88.5% |
| FY 2020 | $0.61 | +122.3% |
| FY 2019 | $-2.74 | -1612.5% |
| FY 2018 | $-0.16 | — |
| FY 2017 | $0.00 | — |
| FY 2016 | $0.00 | — |
Source: Amneal Pharmaceuticals, Inc. SEC filings — income statement (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open AMRX 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Amneal Pharmaceuticals, Inc. reported $0.22 of earnings per share for fiscal 2025. That was 157.9% higher than fiscal 2024. Compared with fiscal 2020, the change was -63.9%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Amneal Pharmaceuticals, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeAmneal Pharmaceuticals, Inc. — frequently asked questions
What is Amneal Pharmaceuticals, Inc.'s earnings per share?
Amneal Pharmaceuticals, Inc. (AMRX) reported earnings per share of $0.22 for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Amneal Pharmaceuticals, Inc.'s official SEC filings (income statement (10-K), split-adjusted), refreshed nightly. Not investment advice.